Part D Plans Need More Leverage Over Specialty Drugs, CMS Official Says
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS Center for Medicare Director Sean Cavanaugh says controlling Medicare drug spending “will be a top priority in the coming years” for the agency.